Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Respiratory syncytial virus Recent news which mentions Respiratory syncytial virus FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach June 07, 2024 Tags Business News Science Respiratory syncytial virus From CNBC.com News Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use April 09, 2024 Tags Health & Science Pharmaceuticals US: News From CNBC.com News RSV vaccine from GSK shows potential to protect adults 50 to 59 October 25, 2023 Tags Respiratory syncytial virus Business News Biotech and Pharmaceuticals From CNBC.com News CDC advisors recommend Pfizer maternal RSV vaccine to protect infants September 22, 2023 Tags Business News Science Respiratory syncytial virus From CNBC.com News FDA approves Pfizer maternal RSV vaccine for infants August 21, 2023 Tags Sanofi SA Science Respiratory syncytial virus From CNBC.com News GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine August 02, 2023 Tags Vaccinations Biotechnology Biotech and Pharmaceuticals From CNBC.com News GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales July 26, 2023 Tags Pharmaceuticals Health & Science US: News From CNBC.com News CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older June 29, 2023 Tags Health & Science Pharmaceuticals Pfizer Inc From CNBC.com News Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis says June 22, 2023 Tags US: News Social issues Pfizer Inc From CNBC.com News CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60 June 21, 2023 Tags GSK plc Business Health care industry From CNBC.com News GSK says RSV vaccine for older adults provides protection over two seasons June 21, 2023 Tags Pharmaceuticals Vaccine controversy Health & Science From CNBC.com News Pfizer RSV vaccine for older adults is only slightly less effective after 18 months June 21, 2023 Tags Health care industry GSK plc Business From CNBC.com News FDA approves Pfizer RSV vaccine for older adults May 31, 2023 Tags U/S/ Economy Politics Disease outbreaks From CNBC.com News Here’s what Pfizer and Moderna say is next for their Covid vaccines May 22, 2023 Tags Health care industry Business Moderna Inc From CNBC.com News FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns May 18, 2023 Tags US: News Pfizer Inc Social issues From CNBC.com News Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say May 16, 2023 Tags Health care industry GSK plc Business From CNBC.com News FDA approves GSK's RSV vaccine for older adults, world's first shot against virus May 03, 2023 Tags Respiratory syncytial virus Vaccinations GSK plc From CNBC.com News FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults February 24, 2023 Tags US: News Pfizer Inc US Economy From CNBC.com News Moderna, Pfizer's new race: The RSV vaccine FDA approval process January 18, 2023 Tags Moderna Inc CNBC Disruptor 50 Respiratory syncytial virus From CNBC.com News A nutritionist shares the best snacks to bring on a plane to boost your immune system December 26, 2022 Tickers LIFE Tags Dietary supplements COVID/19 Health From CNBC.com News Why flu season is so bad this year November 10, 2022 Tickers LIFE Tags Business Health care industry Science From CNBC.com News Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows November 01, 2022 Tags World News Business Pandemics From CNBC.com News Sanofi-AstraZeneca Say New Nirsevimab Data Reinforce Efficacy Against RSV May 11, 2022 Tickers AZN AZNCF SNY Tags AZN Large Cap Biotech From Benzinga Pfizer's RSV Vaccine Candidate Receives FDA Breakthrough Therapy Tag For Prevention of RSV In Older Adults March 24, 2022 Tickers PFE Tags PFE Benzinga FDA From Benzinga Johnson & Johnson Posts Additional RSV Vaccine Data December 07, 2021 Tickers JNJ Tags News REspiratory syncytial virus Briefs From Benzinga J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults October 04, 2021 Tickers JNJ Tags Market News JNJ Phase 2 Trial From Benzinga Pfizer Starts Late-Stage Trial For RSV Vaccine Candidate In Older Patients September 02, 2021 Tickers PFE Tags Benzinga PFE Market News From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.